PIMCO Preferred and [PRFD] vs Sagimet Biosciences [SGMT] Detailed Stock Comparison
PIMCO Preferred and
NYSE
Loading...
Sagimet Biosciences
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: PIMCO Preferred and wins in 6 metrics, Sagimet Biosciences wins in 4 metrics, with 0 ties. PIMCO Preferred and appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | PIMCO Preferred and | Sagimet Biosciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.32 | -5.03 | Sagimet Biosciences |
| Price-to-Book Ratio | N/A | 1.80 | N/A |
| Debt-to-Equity Ratio | 8.55 | 0.12 | Sagimet Biosciences |
| PEG Ratio | N/A | -0.18 | N/A |
| EV/EBITDA | 1.03 | -2.05 | Sagimet Biosciences |
| Profit Margin (TTM) | 53.35% | 0.00% | PIMCO Preferred and |
| Operating Margin (TTM) | N/A | 0.00% | N/A |
| Return on Equity | 43.00% | -37.89% | PIMCO Preferred and |
| Return on Assets (TTM) | 1.24% | -25.61% | PIMCO Preferred and |
| Free Cash Flow (TTM) | N/A | $-42.44M | N/A |
| 1-Year Return | 0.96% | 69.61% | Sagimet Biosciences |
| Price-to-Sales Ratio (TTM) | 0.00 | N/A | N/A |
| Enterprise Value | $54.53B | $111.83M | PIMCO Preferred and |
| EV/Revenue Ratio | 0.23 | N/A | N/A |
| Gross Profit Margin (TTM) | 57.62% | N/A | N/A |
| Revenue per Share (TTM) | $2,200 | $0 | PIMCO Preferred and |
| Earnings per Share (Diluted) | $158.48 | $-1.86 | PIMCO Preferred and |
| Beta (Stock Volatility) | N/A | 3.27 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
PIMCO Preferred and vs Sagimet Biosciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| PIMCO Preferred and | 0.06% | -0.39% | 0.56% | 1.85% | 5.15% | 2.68% |
| Sagimet Biosciences | 0.41% | 5.64% | 3.98% | -15.78% | 276.80% | 62.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| PIMCO Preferred and | 0.96% | 176.15% | 126.49% | 345.56% | 1,269.76% | 1,269.76% |
| Sagimet Biosciences | 69.61% | -54.14% | -54.14% | -54.14% | -54.14% | -54.14% |
News Based Sentiment: PIMCO Preferred and vs Sagimet Biosciences
PIMCO Preferred and
News based Sentiment: NEUTRAL
The sole event this month was a routine dividend payment, indicating stability but lacking any major strategic shifts or performance surprises. This is a consistent payout, but doesn't represent a significant change in the investment story.
Sagimet Biosciences
News sentiment data is not available for Sagimet Biosciences at this time.
Performance & Financial Health Analysis: PIMCO Preferred and vs Sagimet Biosciences
| Metric | PRFD | SGMT |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $249.31M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 31,750 | 443,270 |
| 90 Day Avg. Volume | 23,083 | 471,207 |
| Last Close | $51.67 | $7.34 |
| 52 Week Range | $48.01 - $53.00 | $1.73 - $11.41 |
| % from 52W High | -2.51% | -35.67% |
| All-Time High | $53.00 (Apr 07, 2025) | $20.71 (Jan 22, 2024) |
| % from All-Time High | -2.51% | -64.56% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.17% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.53% | 0.00% |
| Operating Margin (TTM) | N/A | 0.00% |
| Return on Equity (TTM) | 0.43% | -0.38% |
| Debt to Equity (MRQ) | 8.55 | 0.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | $4.04 |
| Cash per Share (MRQ) | N/A | $3.86 |
| Operating Cash Flow (TTM) | $-27,761,000,000 | $-54,230,000 |
| Levered Free Cash Flow (TTM) | $17.53B | $-35,545,376 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: PIMCO Preferred and vs Sagimet Biosciences
| Metric | PRFD | SGMT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.32 | -5.03 |
| Forward P/E | N/A | -2.05 |
| PEG Ratio | N/A | -0.18 |
| Price to Sales (TTM) | 0.00 | N/A |
| Price to Book (MRQ) | N/A | 1.80 |
| Market Capitalization | ||
| Market Capitalization | $0 | $249.31M |
| Enterprise Value | $54.53B | $111.83M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.23 | N/A |
| Enterprise to EBITDA | 1.03 | -2.05 |
| Risk & Other Metrics | ||
| Beta | N/A | 3.27 |
| Book Value per Share (MRQ) | N/A | $4.04 |
Financial Statements Comparison: PIMCO Preferred and vs Sagimet Biosciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PRFD | SGMT |
|---|---|---|
| Revenue/Sales | N/A | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | $15.34M |
| Operating Income (EBIT) | N/A | $-19.87M |
| EBITDA | N/A | $-19.87M |
| Pre-Tax Income | N/A | $-18.18M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | $-18.18M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PRFD | SGMT |
|---|---|---|
| Cash & Equivalents | N/A | $64.72M |
| Total Current Assets | N/A | $146.07M |
| Total Current Liabilities | N/A | $7.18M |
| Long-Term Debt | N/A | N/A |
| Total Shareholders Equity | N/A | $138.99M |
| Retained Earnings | N/A | $-313.49M |
| Property, Plant & Equipment | N/A | $38,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PRFD | SGMT |
|---|---|---|
| Operating Cash Flow | N/A | $-16.70M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $-14.54M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PRFD | SGMT |
|---|---|---|
| Shares Short | N/A | 3.11M |
| Short Ratio | N/A | 5.61 |
| Short % of Float | N/A | 0.11% |
| Average Daily Volume (10 Day) | 31,750 | 443,270 |
| Average Daily Volume (90 Day) | 23,083 | 471,207 |
| Shares Outstanding | 109.76M | 32.20M |
| Float Shares | N/A | 22.63M |
| % Held by Insiders | N/A | 0.10% |
| % Held by Institutions | N/A | 0.29% |
Dividend Analysis & Yield Comparison: PIMCO Preferred and vs Sagimet Biosciences
| Metric | PRFD | SGMT |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $10.29 | N/A |
| 3-Year Avg Dividend Yield | 12.79% | N/A |
| 3-Year Total Dividends | $30.88 | N/A |
| Ex-Dividend Date | Mar 01, 2024 | N/A |